BioSpace News Archive

Kevil brings global scientific expertise to advance JanOne’s drug development portfolio and advise on upcoming Phase 2b clinical trials for PAD

In an effort to show how advances in science are being harnessed in the fight against lung cancer, The LungXperience, an educational exhibit sponsored by AstraZeneca, will be making a stop at the Houston Marathon Health and Fitness EXPO.

The funding will enable Nicoya to expedite the development of new products focused on drug discovery, grow its team from 50 employees to 80 over the next year, expand its reach to more international markets, and target new opportunities within the biotechnology and pharmaceutical industries.

New Japanese Patent Further Strengthens Intellectual Property Portfolio Covering Company’s Novel Platform for Precisely Controlling Core Cell Migration Mechanisms

Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced the appointment of Sheena K. Aurora, MD, as Vice President of Medical Affairs – Migraine Franchise.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is happy to provide the investment community with a review of the many challenges overcome and accomplishments achieved in 2019, with a vision for revenue and growth in 2020 by Generex President & CEO Joseph Moscato.

Company is providing impacted residents with advance prescription benefits, product donations

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading companies in the diagnostic imaging business, does not comment on pending litigations per its corporate policy.

Warrant holders will continue to be able to exercise their Warrants on a cash basis as well.

As Cerner supports clients through the next era of health care digitization, this achievement signals the company’s continued commitment to enhancing the client experience and meeting the needs of an evolving, complex industry.